Development of a Novel Pralidoxime Chloride Auto-Injector Device (UNO-2-PAM)s
Award Notice Posted
- Solicitation number
- 75A50124C00010
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Kaleo, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50124C00010 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Richmond, Virginia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice is from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response for the development of a novel pralidoxime chloride auto-injector device. The awarded contract to KALEO, INC. is for $27,139,602.00 and includes the establishment of a 2-PAM formulation, the development of a delivery device, and regulatory management and operations to support submission and approval of a New Drug Application.
Notice text
The objectives of this contract is : (1)establishment of a 2-PAM formulation utilizing a drug cartridge suitable for an auto-injector; (2)development of a device to deliver the 2-PAM formulation intramuscularly; and (3) regulatory managementand operations to support submission and approval of a New Drug Application (NDA).
Awarded contract 75A50124C00010 to KALEO, INC. for 27139602.00 on 2024-04-11.
Notice history
5 of 13 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity